Related Experiment Video

Updated: Jun 20, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

[Combating the new influenza A (H1N1) virus. I. Overview of the relevant virological aspects]

Marion P G Koopmans1, Adam Meijer, Mariken I M van der Lubben

  • 1Rijksinstituut voor Volksgezondheid en Milieu, Bilthoven, The Netherlands.

Nederlands Tijdschrift Voor Geneeskunde
|September 30, 2009
PubMed

Insights

A novel influenza A (H1N1) virus emerged in 2009, spreading globally. While initially mild, its mutation potential necessitates surveillance and hygiene measures to mitigate impact.

Area of Science:

  • Virology
  • Epidemiology

Context:

  • Emergence of a novel influenza A (H1N1) virus in April 2009.
  • Global spread originating from Mexico.
  • Genetic relation to swine flu viruses, distinct from human strains.

Purpose:

  • To describe the characteristics and implications of the novel influenza A (H1N1) virus.
  • To outline public health responses and strategies for containment.

Summary:

  • The new influenza A (H1N1) virus is highly transmissible between humans.
  • Limited pre-existing population immunity poses a risk.
  • The virus's mild course may change with mutation; severity is uncertain.
  • General practitioners play a key role in surveillance and patient management.
  • Community Health Services require notification for suspected cases.

Impact:

  • Hygiene measures and antivirals can slow transmission.
  • Delaying widespread outbreaks allows time for vaccine development.
  • Highlights the importance of rapid response to novel viral threats.

More Related Videos

Nasal Wipes for Influenza A Virus Detection and Isolation from Swine05:59

Nasal Wipes for Influenza A Virus Detection and Isolation from Swine

Published on: December 4, 2015

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...